NASDAQ:XRTX Xyratex (XRTX) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free XRTX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$2.51▼$2.8450-Day Range N/A52-Week Range N/AVolume26,335 shsAverage Volume17,982 shsMarket Capitalization$5.18 millionP/E RatioN/ADividend YieldN/APrice Target$14.00 Stock AnalysisStock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesShort InterestSocial MediaStock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesShort InterestSocial Media Get Xyratex alerts: Email Address Xyratex MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside382.5% Upside$14.00 Price TargetShort InterestHealthy0.47% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.25 out of 5 stars 3.5 Analyst's Opinion Consensus RatingXyratex has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageXyratex has received no research coverage in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.47% of the float of Xyratex has been sold short.Short Interest Ratio / Days to CoverXyratex has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Xyratex has recently decreased by 59.72%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldXyratex does not currently pay a dividend.Dividend GrowthXyratex does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for XRTX. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 2 news articles for Xyratex this week, compared to 0 articles on an average week. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Xyratex insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.90% of the stock of Xyratex is held by insiders.Percentage Held by InstitutionsOnly 0.23% of the stock of Xyratex is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Xyratex is -2.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Xyratex is -2.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioXyratex has a P/B Ratio of 1.25. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About Xyratex Stock (NASDAQ:XRTX)Xyratex Ltd (Xyratex) is a provider of data storage technology, including modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. Xyratex operates in two segments: Networked Storage Solutions (NSS) and Storage Infrastructure (SI). Its NSS products are primarily HDD based data storage subsystems and solutions, which it provides to original equipment manufacturers. Its SI products consist of HDD manufacturing process equipment, which it sells directly to manufacturers of HDDs and their component suppliers. Its product and solution portfolio for the enterprise data storage industry includes storage enclosures, integrated application platforms and high performance computing (HPC) data storage solutions. In April 2014, Seagate Technology PLC completed the acquisition of Xyratex Ltd.Read More Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… XRTX Stock News HeadlinesApril 22, 2024 | globenewswire.comXORTX Announces Publication of Key Research in ADPKDApril 8, 2024 | globenewswire.comXORTX Welcomes New Member to the Board of DirectorsApril 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.April 5, 2024 | morningstar.comXORTX Therapeutics Inc XRTXApril 1, 2024 | nasdaq.comXORTX Therapeutics Inc. Common Stock (XRTX)March 27, 2024 | globenewswire.comXORTX Announces New Clinical Advisory Board MemberMarch 19, 2024 | finance.yahoo.comXORTX: A Year of Milestones and Strategic Advancements as it Readies for a Registration Clinical TrialMarch 19, 2024 | globenewswire.comXORTX Highlights Achievements of 2023 and Preparation for Registration Clinical TrialApril 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.March 11, 2024 | finance.yahoo.comXORTX Reprices Warrants Issued in Connection with Previous Private PlacementsMarch 4, 2024 | globenewswire.comXORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of UnitsFebruary 15, 2024 | finance.yahoo.comXORTX Raises $2.5 Million Under Prospectus Supplement and Concurrent Private Placement for the Offering of UnitsFebruary 2, 2024 | finance.yahoo.comXORTX Files an Amended and Restated Prospectus Supplement for the Offering of UnitsJanuary 15, 2024 | finance.yahoo.comXORTX Announces $2 Million Public OfferingJanuary 5, 2024 | benzinga.comXORTX Therapeutics Stock (NASDAQ:XRTX), Analyst Ratings, Price Targets, PredictionsJanuary 3, 2024 | finance.yahoo.comXORTX Submits a New Patent for the Treatment of Chronic Kidney DiseaseNovember 30, 2023 | finance.yahoo.comXORTX Announces US ATM OfferingNovember 29, 2023 | finance.yahoo.comXORTX Meets Nasdaq Continued Listing RequirementsNovember 10, 2023 | finance.yahoo.comXORTX Clarifies Timing for Share ConsolidationNovember 8, 2023 | finance.yahoo.comXORTX Announces Share ConsolidationNovember 2, 2023 | finance.yahoo.comXORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2023October 27, 2023 | finance.yahoo.comXORTX Announces Results of Special Meeting of ShareholdersOctober 25, 2023 | finance.yahoo.comXORTX Announces Date for Rescheduled Special Meeting of ShareholdersOctober 25, 2023 | finance.yahoo.comXORTX Announces Rescheduling of Special Meeting of ShareholdersOctober 4, 2023 | finance.yahoo.comXORTX Calls Special Meeting of ShareholdersSeptember 28, 2023 | finance.yahoo.comXORTX Sponsored Study Selected for Presentation at the American Society of Nephrology – Kidney Week 2023September 7, 2023 | finance.yahoo.comXORTX Joins the Kidney Foundation and Kidney MarchSee More Headlines Receive XRTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Xyratex and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/02/2024Today4/25/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:XRTX CUSIPN/A CIK1284823 Webwww.xyratex.com Phone+44-23-92496000FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price Target$14.00 High Stock Price Target$14.00 Low Stock Price Target$14.00 Potential Upside/Downside+382.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.0902) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-2,160,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-85.33% Return on Assets-78.45% Debt Debt-to-Equity RatioN/A Current Ratio13.79 Quick Ratio9.43 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$2.32 per share Price / Book1.25Miscellaneous Outstanding Shares2,000,000Free Float1,861,000Market Cap$5.80 million OptionableNot Optionable Beta0.61 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesErnest J. Sampias (Age 62)Interim Chief Executive Officer, Director Richard Pearce (Age 42)Chief Financial Officer, Director Kenneth Todd Gresham (Age 55)Senior Vice President - Marketing, Sales and Field Support Doug Inamine (Age 47)Senior Vice President - Human Resources Luciano Marinaccio (Age 47)Senior Vice President - Global Operations Ed Prager (Age 48)Senior Vice President - Research and Development Ahmed Shihab (Age 42)Senior Vice President - Business Line Management Jonathan Brooks (Age 61)Non-Executive Independent Chairman of the Board Vadim Perelman (Age 33)Director Ken TraubDirectorMore ExecutivesKey CompetitorsXenetic BiosciencesNASDAQ:XBIOAvenue TherapeuticsNASDAQ:ATXIHoth TherapeuticsNASDAQ:HOTHAyala PharmaceuticalsNASDAQ:ADXSVaccinexNASDAQ:VCNXView All Competitors XRTX Stock Analysis - Frequently Asked Questions Should I buy or sell Xyratex stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Xyratex in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" XRTX shares. View XRTX analyst ratings or view top-rated stocks. What is Xyratex's stock price target for 2024? 1 analysts have issued 12-month price targets for Xyratex's stock. Their XRTX share price targets range from $14.00 to $14.00. On average, they expect the company's share price to reach $14.00 in the next twelve months. This suggests a possible upside of 382.5% from the stock's current price. View analysts price targets for XRTX or view top-rated stocks among Wall Street analysts. Are investors shorting Xyratex? Xyratex saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 8,500 shares, a decline of 59.7% from the March 31st total of 21,100 shares. Based on an average trading volume of 47,700 shares, the short-interest ratio is presently 0.2 days. Currently, 0.5% of the company's shares are short sold. View Xyratex's Short Interest. When is Xyratex's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our XRTX earnings forecast. How were Xyratex's earnings last quarter? Xyratex Ltd (NASDAQ:XRTX) announced its earnings results on Tuesday, April, 2nd. The technology company reported ($0.48) earnings per share for the quarter. When did Xyratex's stock split? Shares of Xyratex reverse split on the morning of Friday, November 10th 2023. The 1-9 reverse split was announced on Friday, November 10th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, November 10th 2023. An investor that had 100 shares of stock prior to the reverse split would have 11 shares after the split. What other stocks do shareholders of Xyratex own? Based on aggregate information from My MarketBeat watchlists, some companies that other Xyratex investors own include Encore Wire (WIRE), Vishay Intertechnology (VSH), Skyworks Solutions (SWKS), SandRidge Energy (SD), NVIDIA (NVDA), Marvell Technology (MRVL), MIPS Technologies (MIPS), Ford Motor (F) and EMC (EMC). This page (NASDAQ:XRTX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican AlternativeThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xyratex Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
